-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Maintains Neutral on CVS Health, Raises Price Target to $71

Benzinga·04/15/2025 12:11:01
Listen to the news
Baird analyst Michael Ha maintains CVS Health (NYSE:CVS) with a Neutral and raises the price target from $51 to $71.